Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Intensity Modulated Radiotherapy (IMRT) for Patients With Primary Bone and Soft Tissue Sarcoma

NCT02520128 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT02520128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02520128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Intensity Modulated Radiotherapy (IMRT) for Patients With Primary Bone and Soft Tissue Sarcoma
Lead sponsor
University College, London
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2016
Completion date
June 30, 2020
Enrollment
191 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

bone sarcoma, chordoma, ewing sarcoma, soft tissue sarcoma, adult